ATE548375T1 - Exemestan und zwischenprodukte davon und verfahren zu dessen herstellung - Google Patents

Exemestan und zwischenprodukte davon und verfahren zu dessen herstellung

Info

Publication number
ATE548375T1
ATE548375T1 AT05711473T AT05711473T ATE548375T1 AT E548375 T1 ATE548375 T1 AT E548375T1 AT 05711473 T AT05711473 T AT 05711473T AT 05711473 T AT05711473 T AT 05711473T AT E548375 T1 ATE548375 T1 AT E548375T1
Authority
AT
Austria
Prior art keywords
formula
exemestane
compound
production
intermediate products
Prior art date
Application number
AT05711473T
Other languages
English (en)
Inventor
Kevin Kunnen
Nathan Stehle
Scot Weis
John Pascone
Richard Pariza
Ornum Scott Van
Paul Zizelman
Original Assignee
Cedarburg Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedarburg Pharmaceuticals Inc filed Critical Cedarburg Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE548375T1 publication Critical patent/ATE548375T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05711473T 2004-01-16 2005-01-14 Exemestan und zwischenprodukte davon und verfahren zu dessen herstellung ATE548375T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53694404P 2004-01-16 2004-01-16
PCT/US2005/001248 WO2005070951A1 (en) 2004-01-16 2005-01-14 Exemestane and its intermediates and methods of making the same

Publications (1)

Publication Number Publication Date
ATE548375T1 true ATE548375T1 (de) 2012-03-15

Family

ID=34807064

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05711473T ATE548375T1 (de) 2004-01-16 2005-01-14 Exemestan und zwischenprodukte davon und verfahren zu dessen herstellung

Country Status (5)

Country Link
US (2) US8183401B2 (de)
EP (1) EP1709062B9 (de)
AT (1) ATE548375T1 (de)
ES (1) ES2382609T3 (de)
WO (1) WO2005070951A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1709062B9 (de) 2004-01-16 2013-02-13 Cedarburg Pharmaceuticals, Inc. Exemestan und zwischenprodukte davon und verfahren zu dessen herstellung
US8168621B2 (en) 2005-09-30 2012-05-01 Endece, Llc 6-substituted estradiol derivatives and methods of use
US10174070B2 (en) 2005-09-30 2019-01-08 Endece Llc 6-substituted estradiol derivatives and methods of use
KR101484134B1 (ko) 2005-09-30 2015-01-21 엔디씨, 엘엘씨 (ｓ)-６-메틸옥사알킬 엑스메스탄 화합물 및 관련 사용방법
EP2099460B1 (de) * 2006-11-30 2016-09-07 Endece, LLC 6-alkoxyalkyl-estradiol-derivate und verfahren zu ihrer verwendung
US20080275259A1 (en) 2007-05-04 2008-11-06 Scinopharm Taiwan, Ltd Process for preparing aromatase inhibitors
EP2170329B1 (de) 2007-06-25 2014-12-17 ScinoPharm Taiwan Ltd. Verfahren zur herstellung eines kristallinen polymorphs aus 7-ethyl-10-hydroxycamptothecin
CA2691772A1 (en) * 2007-06-25 2008-12-31 Scinopharm Taiwan Ltd. Crystalline polymorph of exemestane
MX343059B (es) 2010-09-14 2016-10-24 Endece Llc Derivados de desmetil-estradiol sustituido en 6 como agonistas de er-beta selectivos.
CN105085599A (zh) * 2014-05-16 2015-11-25 绍兴文理学院 一种依西美坦中间体17,17-乙二氧基-6-亚甲基雄甾-1,4-二烯-3-酮及其制备方法和应用
CN106243179B (zh) * 2016-07-31 2018-09-11 南京臣功制药股份有限公司 一种依西美坦工业化生产方法
EP3681491A4 (de) 2017-09-11 2021-06-30 Atossa Therapeutics, Inc. Verfahren zur herstellung und verwendung von endoxifen
US12201591B2 (en) 2019-07-03 2025-01-21 Atossa Therapeutics, Inc. Sustained release compositions of endoxifen

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805231A (en) * 1956-06-06 1957-09-03 Searle & Co 1-hydroxy-4-androstene-3, 17-dione and esters thereof
US3850911A (en) * 1960-09-22 1974-11-26 G Hughes Steroid synthesis
NL122154C (de) * 1963-10-18
US3404150A (en) * 1966-05-25 1968-10-01 Syntex Corp Process for the esterification of hydroxy steroids
US3634469A (en) * 1968-10-16 1972-01-11 Searle & Co Methylenated steroids and process
US4474701A (en) * 1983-03-10 1984-10-02 Veb Jenapharm Jena Process for the separation of 4-androsten-3,17-dione and 1,4-androstadien-3,17-dione
SE8303031D0 (sv) * 1983-05-30 1983-05-30 Leo Ab Improved steroid esters preparation
GB8517360D0 (en) * 1985-07-09 1985-08-14 Erba Farmitalia Substituted androsta-1,4-diene-3,17-diones
DD258820A1 (de) 1986-06-13 1988-08-03 Adw Ddr Verfahren zur herstellung von 6beta-hydroxy-methyl-androsta-1,4-dien-3,17-dion
GB8617107D0 (en) * 1986-07-14 1986-08-20 Erba Farmitalia 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
DE3714965A1 (de) * 1987-04-30 1988-11-10 Schering Ag 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
GB8721383D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia Preparation of methylene derivatives
DD264220A1 (de) * 1987-09-23 1989-01-25 Adw Ddr Verfahren zur herstellung von 6-methylen-androsta-1,4-dien-3,17-dion
GB8801697D0 (en) * 1988-01-26 1988-02-24 Erba Farmitalia Improvements in synthesis of 6-methylene derivatives of androsta-1 4-diene-3 17-dione
US5227375A (en) * 1990-02-08 1993-07-13 Endorecherche, Inc. Aromatase inhibitors
EP1709062B9 (de) 2004-01-16 2013-02-13 Cedarburg Pharmaceuticals, Inc. Exemestan und zwischenprodukte davon und verfahren zu dessen herstellung
KR101484134B1 (ko) * 2005-09-30 2015-01-21 엔디씨, 엘엘씨 (ｓ)-６-메틸옥사알킬 엑스메스탄 화합물 및 관련 사용방법
US20080275259A1 (en) * 2007-05-04 2008-11-06 Scinopharm Taiwan, Ltd Process for preparing aromatase inhibitors

Also Published As

Publication number Publication date
US20120209016A1 (en) 2012-08-16
US20080234505A1 (en) 2008-09-25
EP1709062A1 (de) 2006-10-11
ES2382609T3 (es) 2012-06-11
US8541609B2 (en) 2013-09-24
WO2005070951A1 (en) 2005-08-04
US8183401B2 (en) 2012-05-22
EP1709062B1 (de) 2012-03-07
EP1709062B9 (de) 2013-02-13
HK1096973A1 (en) 2007-06-15
EP1709062A4 (de) 2010-05-26

Similar Documents

Publication Publication Date Title
ATE548375T1 (de) Exemestan und zwischenprodukte davon und verfahren zu dessen herstellung
MA32246B1 (fr) Dérivés polysubstitues de 2-aryl-6-phenyl-imidazo[1,2- a]pyridines, leur préparation et leur application en thérapeutique
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
JO2643B1 (en) Derivatives of 2-aryl-6-phenylimidazole [a-1,2] pyridine, their preparation and therapeutic use
MX2009012885A (es) Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene, como sustituyente, grupo fenilo que tiene estructura de ester de acido sulfonico o estructura de amida de acido sulfonico introducida en este, y tiene actividad de enlace al receptor de gluco
DK1678119T3 (da) Fremgangsmåde til fremstilling af 2-dihalogenacyl-3-amino-acrylsyreestere og 3-dihalogenmethyl-pyrazol-4-carboxylsyreestere
DE602005023459D1 (de) Verfahren zur herstellung und reinigung von 2-hydrocarbyl-3,3-bis(4-hydroxyaryl-phthalimidin-monomeren
DE60316728D1 (de) Phosphonium- und imidazoliumsalze und verfahren zu deren herstellung
NO20083408L (no) Korrosjonsinhibitorer som har okt biologisk nedbrytbarhet og redusert giftighet
JO2808B1 (en) Compounds and their preparation and pharmaceutical compounds
MX2019000035A (es) Composicion de amina util para producir espuma de poliuretano.
EP1741714A4 (de) Heterocyclische verbindung und mittel gegen maligne tumore, das diese enthält
MA32976B1 (fr) Derives de 2-pyridin-2-yl-pyrazol-3(2h)-one, leur preparation et leur application en therapeutique comme activateurs de hif
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten
TW200604161A (en) Chemical process
EA200300458A1 (ru) Новые соединения аминотриазолона, способ их получения и фармацевтические композиции, содержащие их
ATE444323T1 (de) Neuartige epoxidverbindungen und verfahren zu ihrer herstellung
EA200700767A1 (ru) Способ получения пиразолов
NO20062492L (no) Fremgangsmate for fremstilling av tubulininhibitorer
NZ580956A (en) Process for preparing exemestane, an aromatase inhibitor
TW200736218A (en) Method for producing tertiary amines
ATE282040T1 (de) 6-phenyl-pyrazolpyrimidine
MX2009012566A (es) Sintesis de oligonucleotidos.
DE502005009657D1 (de) Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten
ATE417043T1 (de) Verfahren zur herstellung von imiquimod und dessen zwischenverbindungen